Codeine/​Chlorpheniramine/​Phenylephrine

Codeine/​Chlorpheniramine/​Phenylephrine

DEA Class; Rx

Common Brand Names; Novahistine DH

  • Antitussives, Narcotic Combos

Dihydrocodeine: Narcotic agonist analgesic with antitussive activity, mu receptor agonist

Chlorpheniramine: Histamine H1-receptor antagonist

Phenylephrine: Alpha-adrenergic stimulator with weak beta-adrenergic activity; produces systemic vasoconstriction of arteries and arterioles.

Indicated for the treatment of  Cough and Congestion

Codeine

  • Hypersensitivity

  • Acute abdominal condition, diarrhea associated w/ toxins, pseudomembranous colitis, respiratory depression

  • Asthma (acute), inflammatory bowel disease, respiratory impairment

Chlorpheniramine

  • Acute asthma, sleep apnea

Phenylephrine

  • Hypsesensitivity

  • Severe HTN, severe CAD

  • Within 14 days of nonselective MAO inhibitor therapy (risk of hypertensive reaction)

  • Newborn, preemies

Codeine

  • Bradycardia, hypotension, tachycardia

  • Confusion, dizziness, false feeling of well being, headache, lightheadedness, malaise, paradoxical CNS stimulation, restlessness, weakness

  • Rash, urticaria

  • Anorexia, nausea, vomiting, xerostomia

  • LFT’s increased

  • Ureteral spasm, urination decreased

  • Dyspnea

  • Burning at injection site, blurred vision, histamine release

Chlorpheniramine

  • Anticholinergic

  • Somnolence

  • Constipation

  • Diarrhea

  • Nausea

  • Vomiting

  • Blurred vision

Codeine

  • Hypotension, with IV use

  • Seizure, with excessive doses

  • Anaphylactoid reaction (rare)

  • Respiratory depression

Phenylephrine

  • Hypertension

  • Severe peripheral and visceral vasoconstriction

  • Pallor

  • Reflex tachycardia

  • Anxiety

  • Dizziness

  • Headache

  • Insomnia,Nervousness

  • Restlessness

  • Metabolic acidosis

  • Gastric irritation

  • Nausea

  • Decreased renal perfusion

  • Extravasation of IV administration may lead to necrosis and sloughing of surrounding tissue

  • Excitability

Codeine

  • Cardiac arrhythmias, drug abuse/dependence, emotional lability, gallbladder disease, head injury, hepatic impairment, hypothyroidism, increased ICP, prostatic hypertrophy, renal impairment, seizures with epilepsy, urethral stricture, urinary tract surgery

  • Risk of life threatening side effects in nursing babies, especially if mother is an ultra rapid metabolizer of codeine

  • Ibuprofen is more effective than codeine for pain from musculoskeletal injuries in children

Chlorpheniramine

  • May cause CNS depression (patient should not operate heavy machinery

  • Caution in patients with asthma, thyroid dysfunction, hypertension, ischemic heart disease, increased intraocular pressure, or prostatic hyperplasia/urinary obstruction

Phenylephrine

  • Caution in diabetes mellitus, cardiovascular disease, prostatic hyperplasia, hyperthyroidism, and increased intraocular pressure

Pregnancy category: C

Not known whether distributed in breast milk, use caution

Adults

5-10 mL PO q4-6hr, up to 40 mL/24 hr

Pediatric

< 2 years: Not recommended

2-6 years: 1.25-2.5 mL PO q4-6hr PRN, up to 10 mL/24 hr

6-12 years: 2.5-5 mL PO q4-6hr, up to 20 mL/24 hr

>12 years: 5-10 mL PO q4-6hr, up to 40 mL/24 hr

Dihydrocodeine/chlorpheniramine/phenylephrine

oral liquid: Schedule III

  • (7.5mg/2mg/5mg)/5mL

oral syrup: Schedule V

  • (3mg/2mg/7.5mg)/5mL
  • (3mg/5mg/20mg)/5mL
DrugsAce
Logo